XBIO icon

Xenetic Biosciences
XBIO

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $535K invested in Xenetic Biosciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11K
2
+$8K
3
+$3.53K

Top Sellers

1
-$30K
2
-$19.4K
3
-$4.5K
4
TRCT
Tower Research Capital (TRC)
New York
-$1.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$331K
2
$62K
3
$49K
4
$19K
5
$15K
6
$11K
7
$10K
8
$10K
9
$8K
10
$6K
11
$6K
12
$4K
13
$4K
14
–